Search

Michael D. Pak

Examiner (ID: 3628, Phone: (571)272-0879 , Office: P/1646 )

Most Active Art Unit
1646
Art Unit(s)
1674, 1621, 1646, 1812, 0
Total Applications
1549
Issued Applications
718
Pending Applications
268
Abandoned Applications
570

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6001704 [patent_doc_number] => 20110117574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'FLUORESCENCE BASED ASSAY TO DETECT SODIUM/CALCIUM EXCHANGER \"FORWARD MODE\" MODULATING COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/922749 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5851 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117574.pdf [firstpage_image] =>[orig_patent_app_number] => 12922749 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/922749
FLUORESCENCE BASED ASSAY TO DETECT SODIUM/CALCIUM EXCHANGER "FORWARD MODE" MODULATING COMPOUNDS Mar 12, 2009 Abandoned
Array ( [id] => 6566502 [patent_doc_number] => 20100234274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Use of Nestafin-1 in the Treatment for Diabetes' [patent_app_type] => utility [patent_app_number] => 12/402848 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5883 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234274.pdf [firstpage_image] =>[orig_patent_app_number] => 12402848 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/402848
Use of Nestafin-1 in the Treatment for Diabetes Mar 11, 2009 Abandoned
Array ( [id] => 7778348 [patent_doc_number] => 20120040938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'GLUCOCORTICOID RECEPTOR ALLELES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/254338 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18207 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040938.pdf [firstpage_image] =>[orig_patent_app_number] => 13254338 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/254338
GLUCOCORTICOID RECEPTOR ALLELES AND USES THEREOF Mar 3, 2009 Abandoned
Array ( [id] => 6185053 [patent_doc_number] => 20110124006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHOD FOR SCREENING OF THERAPEUTIC AGENT FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/921015 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 9052 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124006.pdf [firstpage_image] =>[orig_patent_app_number] => 12921015 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/921015
METHOD FOR SCREENING OF THERAPEUTIC AGENT FOR CANCER Feb 26, 2009 Abandoned
Array ( [id] => 6175778 [patent_doc_number] => 20110177502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME' [patent_app_type] => utility [patent_app_number] => 12/735843 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29433 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177502.pdf [firstpage_image] =>[orig_patent_app_number] => 12735843 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/735843
IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME Feb 18, 2009 Abandoned
Array ( [id] => 5480666 [patent_doc_number] => 20090203623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/368935 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20763 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203623.pdf [firstpage_image] =>[orig_patent_app_number] => 12368935 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/368935
METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST Feb 9, 2009 Abandoned
Array ( [id] => 5385711 [patent_doc_number] => 20090226956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'RUNX-MEDIATED ACTION OF NUCLEAR RECEPTORS AND UTILITIES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/367493 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 32652 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226956.pdf [firstpage_image] =>[orig_patent_app_number] => 12367493 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/367493
RUNX-MEDIATED ACTION OF NUCLEAR RECEPTORS AND UTILITIES THEREOF Feb 5, 2009 Abandoned
Array ( [id] => 9850016 [patent_doc_number] => 08951742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof' [patent_app_type] => utility [patent_app_number] => 12/363932 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19487 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12363932 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/363932
Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof Feb 1, 2009 Issued
Array ( [id] => 5458271 [patent_doc_number] => 20090258423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Cell cycle regulation and differentiation' [patent_app_type] => utility [patent_app_number] => 12/321952 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 32082 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258423.pdf [firstpage_image] =>[orig_patent_app_number] => 12321952 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/321952
Cell cycle regulation and differentiation Jan 25, 2009 Issued
Array ( [id] => 5354682 [patent_doc_number] => 20090186026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'EPHRIN AND EPH RECEPTOR AGONISTS FOR MODULATION OF BONE FORMATION AND RESORPTION' [patent_app_type] => utility [patent_app_number] => 12/354892 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13602 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186026.pdf [firstpage_image] =>[orig_patent_app_number] => 12354892 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/354892
EPHRIN AND EPH RECEPTOR AGONISTS FOR MODULATION OF BONE FORMATION AND RESORPTION Jan 15, 2009 Abandoned
Array ( [id] => 7586769 [patent_doc_number] => 20110281279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'CIRCULATING Epha2 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/808470 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7858 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281279.pdf [firstpage_image] =>[orig_patent_app_number] => 12808470 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/808470
CIRCULATING Epha2 RECEPTOR Dec 16, 2008 Abandoned
Array ( [id] => 8772195 [patent_doc_number] => 08426147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'RORS as modifiers of the p21 pathway and methods of use' [patent_app_type] => utility [patent_app_number] => 12/325914 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15866 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12325914 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/325914
RORS as modifiers of the p21 pathway and methods of use Nov 30, 2008 Issued
Array ( [id] => 6264683 [patent_doc_number] => 20100297615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'EGFR MUTATIONS' [patent_app_type] => utility [patent_app_number] => 12/272321 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8920 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297615.pdf [firstpage_image] =>[orig_patent_app_number] => 12272321 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/272321
EGFR mutations Nov 16, 2008 Issued
Array ( [id] => 6234900 [patent_doc_number] => 20100266604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'USE OF TAM RECEPTOR INHIBITORS AS IMMUNOENHANCERS AND TAM ACTIVATORS AS IMMUNOSUPPRESSORS' [patent_app_type] => utility [patent_app_number] => 12/741797 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 43206 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266604.pdf [firstpage_image] =>[orig_patent_app_number] => 12741797 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/741797
USE OF TAM RECEPTOR INHIBITORS AS IMMUNOENHANCERS AND TAM ACTIVATORS AS IMMUNOSUPPRESSORS Nov 6, 2008 Abandoned
Array ( [id] => 5434957 [patent_doc_number] => 20090169543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Method for regulating immune function in primates using the Foxp3 protein' [patent_app_type] => utility [patent_app_number] => 12/291359 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23976 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169543.pdf [firstpage_image] =>[orig_patent_app_number] => 12291359 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/291359
Method for regulating immune function in primates using the Foxp3 protein Nov 5, 2008 Abandoned
Array ( [id] => 5391237 [patent_doc_number] => 20090208550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Methods and compositions for treating hepatic diseases' [patent_app_type] => utility [patent_app_number] => 12/290021 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20969 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208550.pdf [firstpage_image] =>[orig_patent_app_number] => 12290021 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/290021
Methods and compositions for treating hepatic diseases Oct 23, 2008 Abandoned
Array ( [id] => 7663653 [patent_doc_number] => 20110312922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'EDTA Resistant S100A12 Complexes (ERAC)' [patent_app_type] => utility [patent_app_number] => 12/738579 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19841 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312922.pdf [firstpage_image] =>[orig_patent_app_number] => 12738579 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738579
EDTA Resistant S100A12 Complexes (ERAC) Oct 16, 2008 Abandoned
Array ( [id] => 6439188 [patent_doc_number] => 20100279314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX' [patent_app_type] => utility [patent_app_number] => 12/738257 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11976 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279314.pdf [firstpage_image] =>[orig_patent_app_number] => 12738257 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738257
COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX Oct 14, 2008 Abandoned
Array ( [id] => 6347974 [patent_doc_number] => 20100330697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/738337 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16840 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330697.pdf [firstpage_image] =>[orig_patent_app_number] => 12738337 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738337
COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME Oct 13, 2008 Abandoned
Array ( [id] => 5422395 [patent_doc_number] => 20090148850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Methods for identifying modulators of P2RY14' [patent_app_type] => utility [patent_app_number] => 12/286566 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 8326 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148850.pdf [firstpage_image] =>[orig_patent_app_number] => 12286566 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/286566
Methods for identifying modulators of P2RY14 Sep 30, 2008 Abandoned
Menu